Neither baseline blood nor sputum eosinophils predict future exacerbations in the SPIROMICS cohort

A. Hastie (Winston-Salem, United States), P. Quibrera (Chapel Hill, United States), D. Couper (Chapel Hill, United States), N. Alexis (Chapel Hill, United States), I. Barjaktarevic (Los Angeles, United States), J. Curtis (Ann Arbor, United States), E. Bleecker (Tucson, United States)

Source: International Congress 2022 – Chronic airway diseases: from phenotypes to severity
Session: Chronic airway diseases: from phenotypes to severity
Session type: Oral Presentation
Number: 1416

Congress or journal article abstractWebcastPDF journal article, handout or slidesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Hastie (Winston-Salem, United States), P. Quibrera (Chapel Hill, United States), D. Couper (Chapel Hill, United States), N. Alexis (Chapel Hill, United States), I. Barjaktarevic (Los Angeles, United States), J. Curtis (Ann Arbor, United States), E. Bleecker (Tucson, United States). Neither baseline blood nor sputum eosinophils predict future exacerbations in the SPIROMICS cohort. 1416

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.